Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

BrainStorm to Continue with Planned Phase 3b Trial and Remains Committed to Advancing Access for People Living with ALS NEW YORK, July 8, 2025 /PRNewswire/ -- BrainStorm ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...

Commonly prescribed medications for anxiety, depression and sleep disorders may be associated with a higher risk of ...

Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with conditions like amyotrophic lateral sclerosis (ALS) or spinal cord injuries ...

JJ Potrikus, vice president of the New York Collegiate Baseball League, joined Bridge Street for details this morning along ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...

Ms Siti Nur Sabrina Anis, 26, had to swop one set of wheels for another – her Yamaha motorcycle for a motorised wheelchair.

On July 4, 1776, the Continental Congress adopted the Declaration of Independence, proclaiming U.S. independence from Britain ...

Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides ...

A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts ...